{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:25:17Z","timestamp":1773271517530,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":4329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1093\/annonc\/mdm483","type":"journal-article","created":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T22:40:18Z","timestamp":1193352018000},"page":"265-268","source":"Crossref","is-referenced-by-count":120,"title":["Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib"],"prefix":"10.1016","volume":"19","author":[{"given":"I.","family":"Tamaskar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bukowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Elson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.","family":"Ioachimescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dreicer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Mekhail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.I.","family":"Rini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdm483_bb0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd2130","article-title":"Discovery and development of sorafenib: a multikinase inhibitor for treating cancer","volume":"5","author":"Wilhelm","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1093\/annonc\/mdm483_bb0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/jnci\/djj069","article-title":"BAY 43-9006 inhibition of oncogenic RET mutants","volume":"98","author":"Carlomagno","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdm483_bb0020","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1200\/JCO.2005.03.6723","article-title":"Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma","volume":"24","author":"Ratain","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm483_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdm483_bb0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jnci\/djk008","article-title":"Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib","volume":"99","author":"Rini","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1093\/annonc\/mdm483_bb0035","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-145-9-200611070-00008","article-title":"Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors","volume":"145","author":"Desai","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdm483_bb0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1677\/joe.0.1660475","article-title":"Angiogenesis in the thyroid gland","volume":"166","author":"Ramsden","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1093\/annonc\/mdm483_bb0045","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1038\/sj.onc.1201456","article-title":"Upregulation of the angiogenic factors PIGF, VEGF and their receptors (Flt-1, Flk-1\/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervacularisation","volume":"15","author":"Viglietto","year":"1997","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdm483_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/joe.0.1570005","article-title":"Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function","volume":"157","author":"Wang","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1093\/annonc\/mdm483_bb0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jemt.10256","article-title":"Angiogenesis in endocrine glands: special reference to the expression of vascular endothelial growth factor","volume":"60","author":"Katoh","year":"2003","journal-title":"Microsc Res Tech"},{"key":"10.1093\/annonc\/mdm483_bb0060","first-page":"327","article-title":"In vivo antitumour activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endotherlial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship","volume":"9","author":"Mendel","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdm483_bb0065","first-page":"571","article-title":"Cloning and expression of the ret proto-oncogene encoding a receptor tyrosine kinase with two potential transmembrane domains","volume":"3","author":"Takahashi","year":"1988","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdm483_bb0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711720305","article-title":"Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin","volume":"172","author":"Nakamura","year":"1994","journal-title":"J Pathol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419413422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419413422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/2\/265\/725260\/mdm483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T13:22:14Z","timestamp":1582204934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419413422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0923753419413422"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdm483","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}